Stonebridge Capital Advisors LLC
Source: SEC Form 13F · as of Mar 2026Stonebridge Capital Advisors LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $91.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$91.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 85,896 | $21.0M |
| MRKMerck & Co., Inc. | 150,773 | $18.1M |
| GILDGILEAD SCIENCES, INC. | 114,880 | $16.0M |
| LLYELI LILLY & Co | 11,358 | $10.4M |
| BMYBRISTOL MYERS SQUIBB CO | 166,362 | $10.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 36,455 | $9.9M |
| ABTABBOTT LABORATORIES | 18,264 | $1.9M |
| IQVIQVIA Holdings Inc. | 8,647 | $1.5M |
| PFEPFIZER INC | 19,985 | $561K |
| PMPhilip Morris International Inc | 2,415 | $399K |
| TECHBIO-TECHNE Corp | 6,750 | $353K |
| MCKMcKesson Corporation | 405 | $350K |
| ABBVAbbVie Inc. | 1,517 | $330K |
| DMACDiaMedica Therapeutics Inc. | 17,500 | $118K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.